Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Shares Issued (2018 - 2024)

Solid Biosciences' Shares Issued history spans 5 years, with the latest figure at $19000.0 for Q4 2024.

  • For Q4 2024, Shares Issued changed N/A year-over-year to $19000.0; the TTM value through Dec 2024 reached $457000.0, down 99.37%, while the annual FY2024 figure was $457000.0, N/A changed from the prior year.
  • Shares Issued for Q4 2024 was $19000.0 at Solid Biosciences, down from $278000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $134.9 million in Q1 2021 and bottomed at -$134.8 million in Q2 2021.
  • The 3-year median for Shares Issued is $86500.0 (2022), against an average of $7.3 million.
  • The largest YoY upside for Shares Issued was 153.79% in 2022 against a maximum downside of 99.98% in 2022.
  • A 3-year view of Shares Issued shows it stood at -$134.8 million in 2021, then soared by 153.79% to $72.5 million in 2022, then plummeted by 99.97% to $19000.0 in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Shares Issued are $19000.0 (Q4 2024), $278000.0 (Q3 2024), and $9000.0 (Q2 2024).